Reverse Engineering of Modified Genes by Bayesian Network Analysis Defines Molecular Determinants Critical to the Development of Glioblastoma

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Kunkle, Brian W ^a   Yoo, Changwon ^a   Roy, Deodutta ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD99 ANTIGEN; COLLAGEN; CYCLIN DEPENDENT KINASE 4; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH HORMONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; VASCULOTROPIN; WNT5A PROTEIN;

ANXA2 GENE; ARTICLE; ASTROCYTOMA; BAYES THEOREM; BTF3 GENE; CANCER GRADING; CD99 GENE; CDK4 GENE; CELL MOTION; COL4A1 GENE; DISEASE COURSE; EARLY DIAGNOSIS; EGFR GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENE REGULATORY NETWORK; GENETIC ENGINEERING; GENETIC RISK; GLIOBLASTOMA; HIF 1ALPHA GENE; HUMAN; IDH3A GENE; MALIGNANT NEOPLASTIC DISEASE; MICROARRAY ANALYSIS; MMP2 GENE; NEUROLOGIC DISEASE; ONCOGENE; ONCOGENE C MYC; PROTEIN DNA INTERACTION; RAB31 GENE; SERBP1 GENE; TOP2A GENE; UPREGULATION; WNT5A GENE;

BAYES THEOREM; CARCINOGENESIS; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; FEMALE; GENE REGULATORY NETWORKS; GENES, NEOPLASM; GLIOBLASTOMA; HUMANS; MALE; MARKOV CHAINS; META-ANALYSIS AS TOPIC; NEOPLASM GRADING; REPRODUCIBILITY OF RESULTS; TRANSCRIPTOME;

EID: 84878517297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064140     Document Type: Article

References (50)

1. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, et al. (2007) Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression Profiles. Neoplasia 9: 166-180.
2. Berriz GF, Beaver JE, Cenik C, Tasan M, Roth FP, (2009) Next generation software for functional trend analysis. Bioinformatics 25: 3043-3044.
3. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
4. Friedman N, Linial M, Nachman I, Pe'er D, (2000) Using Bayesian networks to analyze expression data. J Comput Biol 7: 601-620.
5. Yoo C, Thorsson V, Cooper GF (2002) Discovery of Causal Relationships in a Gene-Regulation Pathway from a Mixture of Experimental and Observational DNA Microarray Data. Pac Symp Biocomput: 498-509.
6. Banjo: Bayesian network inference with java objects. 2.2.0 ed: Duke University.
7. Bansal M, di Bernardo D, (2007) Inference of gene networks from temporal gene expression profiles. IET Syst Biol 1: 306-312.
8. Charniak E, (1991) Bayesian Networks without Tears. AI Magazine 12: 50-62.
9. Hartemink AJ, (2005) Reverse engineering gene regulatory networks. Nat Biotechnol 23: 554-555.
10. Yoo C, Brilz EM, (2009) The five-gene-network data analysis with local causal discovery algorithm using causal Bayesian networks. Ann N Y Acad Sci 1158: 93-101.
11. Pe'er D, Regev A, Elidan G, Friedman N, (2001) Inferring subnetworks from perturbed expression profiles. Bioinformatics 17Suppl 1: S215-224.
12. Zhu J, Zhang B, Smith EN, Drees B, Brem RB, et al. (2008) Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet 40: 854-861.
13. Druzdzel MJ (1999) SMILE: Structural modeling, inference, and learning engine and GeNIe: A development environment for graphical decision-theoretic models. Menol Park, CA. AAAI Press/The MIT Press.
14. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al. (2011) SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute.
15. Glez-Pena D, Reboiro-Jato M, Dominguez R, Gomez-Lopez G, Pisano DG, et al. (2010) PathJam: a new service for integrating biological pathway information. J Integr Bioinform 7.
16. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, et al. (2005) Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 65: 8679-8689.
17. Gutmann DH, Hedrick NM, Li J, Nagarajan R, Perry A, et al. (2002) Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas. Cancer Res 62: 2085-2091.
18. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
19. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, et al. (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 102: 5814-5819.
20. Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, et al. (2001) Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 61: 6885-6891.
21. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, et al. (2003) Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 22: 4918-4923.
22. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, et al. (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300.
23. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, et al. (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64: 6892-6899.
24. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, et al. (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6: 217-223.
25. Huse JT, Holland EC, (2010) Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10: 319-331.
26. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
27. de la Fuente A, (2010) From 'differential expression' to 'differential networking'- identification of dysfunctional regulatory networks in diseases. Trends Genet 26: 326-333.
28. Khatri P, Draghici S, (2005) Ontological analysis of gene expression data: current tools, limitations, and open problems. Bioinformatics 21: 3587-3595.
29. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, et al. (2005) Reverse engineering of regulatory networks in human B cells. Nat Genet 37: 382-390.
30. Yu J, Smith VA, Wang PP, Hartemink AJ, Jarvis ED (2002) Using Bayesian Network Inference Algorithms to Recover Molecular Genetic Regulatory Networks; Stockholm, Sweden. Karolinska Institute.
31. Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, et al. (2009) A network model of a cooperative genetic landscape in brain tumors. JAMA 302: 261-275.
32. Liu Y, Carson-Walter EB, Cooper A, Winans BN, Johnson MD, et al. (2010) Vascular gene expression patterns are conserved in primary and metastatic brain tumors. J Neurooncol 99: 13-24.
33. Guillamo JS, de Bouard S, Valable S, Marteau L, Leuraud P, et al. (2009) Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma. Clin Cancer Res 15: 3697-3704.
34. Mukherjee B, McEllin B, Camacho CV, Tomimatsu N, Sirasanagandala S, et al. (2009) EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Res 69: 4252-4259.
35. Idbaih A, Aimard J, Boisselier B, Marie Y, Paris S, et al. (2009) Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma. Neuropathol Appl Neurobiol 35: 208-213.
36. Ruano Y, Ribalta T, de Lope AR, Campos-Martin Y, Fiano C, et al. (2009) Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. Am J Clin Pathol 131: 257-263.
37. Odreman F, Vindigni M, Gonzales ML, Niccolini B, Candiano G, et al. (2005) Proteomic studies on low- and high-grade human brain astrocytomas. J Proteome Res 4: 698-708.
38. Kusumawidjaja G, Kayed H, Giese N, Bauer A, Erkan M, et al. (2007) Basic transcription factor 3 (BTF3) regulates transcription of tumor-associated genes in pancreatic cancer cells. Cancer Biol Ther 6: 367-376.
39. Guerreiro AS, Fattet S, Kulesza DW, Atamer A, Elsing AN, et al. (2011) A sensitized RNA interference screen identifies a novel role for the PI3K p110gamma isoform in medulloblastoma cell proliferation and chemoresistance. Mol Cancer Res 9: 925-935.
40. Ng EL, Ng JJ, Liang F, Tang BL, (2009) Rab22B is expressed in the CNS astroglia lineage and plays a role in epidermal growth factor receptor trafficking in A431 cells. J Cell Physiol 221: 716-728.
41. Serao NV, Delfino KR, Southey BR, Beever JE, Rodriguez-Zas SL, (2011) Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med Genomics 4: 49.
42. Wiedemeyer WR, Dunn IF, Quayle SN, Zhang J, Chheda MG, et al. (2010) Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Proc Natl Acad Sci U S A 107: 11501-11506.
43. Nobusawa S, Lachuer J, Wierinckx A, Kim YH, Huang J, et al. (2010) Intratumoral patterns of genomic imbalance in glioblastomas. Brain Pathol 20: 936-944.
44. Ishizawa K, Komori T, Shimada S, Hirose T, (2008) Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors. Clin Neuropathol 27: 118-128.
45. An JH, Lee SY, Jeon JY, Cho KG, Kim SU, et al. (2009) Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J Proteome Res 8: 2873-2881.
46. Tatenhorst L, Rescher U, Gerke V, Paulus W, (2006) Knockdown of annexin 2 decreases migration of human glioma cells in vitro. Neuropathol Appl Neurobiol 32: 271-277.
47. Dawany NB, Dampier WN, Tozeren A, (2011) Large-scale integration of microarray data reveals genes and pathways common to multiple cancer types. Int J Cancer 128: 2881-2891.
48. Ladha J, Donakonda S, Agrawal S, Thota B, Srividya MR, et al. (2010) Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes. Cancer Res 70: 6437-6447.
49. Nakahara Y, Shiraishi T, Okamoto H, Mineta T, Oishi T, et al. (2004) Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization. Neuro Oncol 6: 281-289.
50. Koensgen D, Mustea A, Klaman I, Sun P, Zafrakas M, et al. (2007) Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression. Gynecol Oncol 107: 266-273.